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PURPOSE
We aimed to assess the technical feasibility of targeted endo-
venous treatment of Giacomini vein insufficiency (GVI)-asso-
ciated varicose disease and report our early results.
METHODS
We retrospectively screened 335 patients with varicose dis-
ease who underwent endovenous laser ablation from Sep-
tember 2011 to January 2013, and determined 17 patients 
who underwent Giacomini vein ablation. Using a targeted 
endovenous treatment approach considering the reflux pat-
tern, all healthy great saphenous veins (GSV) or vein seg-
ments were preserved while all insufficient veins (Giacomini 
vein, perforator veins, small saphenous vein, anterior acces-
sory GSV, major tributary veins, or incompetent segments of 
the GSV) were ablated. Treatment success was analysed using 
Doppler findings and clinical assessment scores before and 
after treatment. 
RESULTS
Targeted endovenous treatment was technically successful in 
all cases. Seven GSVs were preserved totally and three GSVs 
were preserved partially (10/17, 58%), with no major com-
plications. Clinical assessment scores and Doppler findings 
were improved in all cases.
CONCLUSION
Targeted endovenous treatment of GVI-associated varicose 
disease is safe and effective. In majority of GVI cases saphe-
nous vein can be preserved using this approach.  
T he Giacomini vein (GV) is defined as a branch of cranial exten-sion of the small saphenous vein (SSV) that connects the SSV with the posterior thigh circumflex vein (PTCV) (1). In 14% of 
the population, SSV continues directly as the GV (2). Although most 
varices are caused by reflux originating from the great saphenous vein 
(GSV), SSV, or accessory saphenous branches, varicose disease caused by 
a Giacomini vein insufficiency (GVI) is not a rare condition (3, 4). GVI 
is commonly seen with varices that arise on the posterior thigh or calf 
and accounts for 4%–6% of cases treated by endovenous laser ablation 
(ELA) (5–8). There is no defined standard treatment for GVI-associated 
varicose disease. Performing a phlebectomy as the only treatment may 
result in recurrent varicose disease for some patients. Classical saphe-
nous vein-focused surgical therapies may result in overtreatment or un-
dertreatment. Targeted endovenous treatment (TET) differs from surgi-
cal treatments by focusing on the reflux sources and preserving healthy 
GSV, either totally or partially, while ablating insufficient segments of 
the vein. The ablation may be applied to any vein including the GV, 
perforator vein, SSV, and anterior accessory GSV, except the deep veins. 
ELA has recently evolved into an accepted option for eliminating 
truncal reflux for an incompetent GSV or SSV, with successful saphe-
nous vein ablation rates ranging from 88% to 100% (9–12). However, 
reports of ELA treatment of the GVI are rare (3, 4, 7, 13). Some authors 
recommend only GSV ablation (4), while others ablate the insufficient 
GV (3). To the best of our knowledge, there is only one study on treat-
ment of GVI considering the reflux pattern, which used both ELA and 
sclerotherapy (13). The present study focuses on the saphenous vein 
sparing effect of TET while treating the GVI by ELA and sclerotherapy. 
Today, reflux sources other than the saphenous veins, such as the 
perforator veins or GVs, are also accessible and can be treated selective-
ly with the help of new endovenous techniques. TET considering the 
various reflux patterns is a minimally invasive and selective treatment 
method for GVI that may prevent unnecessary saphenous ablations in 
some cases. The purpose of this study was to evaluate the technical fea-
sibility of TET and report early treatment results of 17 patients who had 
GVI with various reflux sources.
Methods
Patients
Between September 2011 and January 2013, 674 consecutive adult pa-
tients presenting with varicose veins were retrospectively evaluated us-
ing clinical and Doppler ultrasonography (US) data by a vascular inter-
ventional radiologist. Of these, 335 patients underwent ELA treatment. 
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Seventeen patients (median age, 36 
years; range, 28–54 years) had GVI, and 
all underwent TET (17/335) (Fig. 1). 
Patients with severe peripheral arterial 
disease, active thrombophlebitis, deep 
vein insufficiency, pregnancy, known 
thrombophilia or coagulation disor-
ders, or a history of deep vein throm-
bosis were not treated and were not 
included in the study. The study was 
approved by the local ethics commit-
tee (reference no: 8951337/1009/128). 
The treatment procedure was ex-
plained and written informed consent 
was obtained from all patients. 
Patient’s demographic information 
and medical histories were recorded. 
The varicose disease was categorized 
using the clinical, etiological, anatom-
ical, and pathophysiological (CEAP) 
classification, and the clinical severity 
was graded using the revised venous 
clinical severity score (rVCSS) as rec-
ommended by the Society of Interven-
tional Radiology (14). 
Each patient underwent a physical 
examination and a Doppler US ex-
amination of both lower extremities, 
while standing, before and after the 
treatment by the same physician who 
performed the ELA procedures. A ve-
nous reflux lasting longer than 0.5 s 
in the superficial veins or the GV and 
longer than 1 s in the deep veins with 
compression and release or the Valsal-
va maneuver was diagnostic for venous 
insufficiency (15). A preoperative reflux 
map was obtained to allow flow-map-
ping for planning the treatment strat-
egy. The same US device with a linear 
transducer (LA523 [6–13 MHz], Esaote 
SpA, Genova, Italy) was used for diag-
nosis, treatment, and postprocedural 
follow-up. The maximum diameter of 
the GV was measured in all patients. 
All GVIs with a straight course were 
treated with ELA. Insufficient segments 
of the saphenous veins were also treat-
ed with ELA in the same session. We ex-
cluded three patients with significantly 
tortuous GVs, for whom ELA could not 
be used and US-guided foam sclerother-
apy had to be performed. Patients, who 
underwent US-guided foam sclerother-
apy as a complementary treatment to 
ELA for residual varicosities in large var-
icose veins, were included. Polidocanol 
(Aethoxysklerol 3%; Chemisce Fabrik 
Kreussler, Wiesbaden, Germany) was 
used as the sclerosing solution with a 
modified Tessari technique (sclerosant 
to air ratio of 1:3). 
Targeted endovascular treatment procedure 
In the TET approach, we aimed to 
detect and ablate all the reflux sources 
and insufficient venous segments. The 
second aim was to preserve the healthy 
GSV totally or partially (only the GSV 
segment proximal to the GSV-PTCV 
junction).
The procedure was performed under 
local anesthesia in an outpatient treat-
ment facility. The incompetent GV was 
punctured at its most caudal level un-
der US guidance for the ELA procedure. 
The laser fiber tip was placed through 
a catheter/sheath at the saphenofemo-
ral junction (SFJ) in patients who also 
had GSV insufficiency or at the PTCV-
GSV junction in patients without GSV 
insufficiency. The tip of the laser was 
placed at a depth of at least 1 cm below 
the fascia in the perforator vein when 
there was a perforator vein reflux. If 
there was no saphenous reflux accom-
panying the GVI, isolated GV ablation 
from the PTCV-GSV junction to the 
SSV-GV junction was performed while 
preserving both saphenous veins. If 
any additional incompetent truncal 
veins or a tributary vein were present, 
these were also ablated at the same ses-
sion. A tumescent anesthetic was in-
jected around the vein under US guid-
ance with a power pump (Klein pump, 
HK Surgical, San Clemente, California, 
USA). A 600 μm bare-tip laser fiber was 
used in continuous mode at 1470 nm 
(Vari-Lase, Vascular solutions, Minne-
apolis, Minnesota, USA) for ELA. The 
energy delivered was 60 J/cm for GVs 
that were 5 mm or less in diameter and 
80 J/cm for the larger veins. Technical 
success in the ELA procedure was de-
fined as successful access, delivery of 
laser energy to the incompetent GV, 
and obliteration of the GV confirmed 
at the first month of follow-up.
Clinical assessment
The patients were evaluated clinical-
ly and by Doppler US one, six, and 12 
months after treatment and annually 
thereafter. Clinical improvement was 
assessed by the clinical aspect of the 
CEAP score and by rVCSS score at six 
months versus pretreatment, which 
were available for all patients. Im-
provement in varicosities was assessed 
by comparing pretreatment photo-
graphs with post-treatment six-month 
photographs. These photographs were 
Figure 1. Flow chart of patients screened retrospectively for inclusion in the analysis. ELA, 
endovenous laser ablation; GVI, Giacomini vein insufficiency; USGFS, ultrasound-guided foam 
sclerotherapy.
Total patients with
varicose veins: 674 210 patients had only
sclerotherapy
315 patients did not 
have GVI
3 patients had severely
tortuous incompetent
GV; treated by USGFS
86 patients had not
undergone the
treatment yet
Exclusion
Exclusion
Selection: 335 patients
treated by ELA
Inclusion: 17 patients with
GVI treated by ELA
43 patients were 
excluded due to general 
exclusion criteria 
(written in text)
categorized as follows: deterioration, 
no change, improvement, and full res-
olution. Any adverse effects, such as 
hyperpigmentation, skin necrosis, al-
lergic reaction, deep vein thrombosis, 
or paresthesia, were also recorded. 
The Wilcoxon test using SPSS ver-
sion 11.0 (SPSS Inc., Chicago, Illinois, 
USA) was used for statistical analysis 
to evaluate the clinical improvement 
after treatment. Null hypothesis of no 
difference was rejected if P value was 
less than 0.05. 
Results
There were eight patients with de-
scending reflux, one patient with as-
cending reflux, two patients with both 
ascending and descending reflux, three 
patients with deep-to-superficial reflux 
via the perforator veins, and three pa-
tients with isolated GVI without any 
obvious reflux origin (Table 1). GVI 
was observed to exhibit three differ-
ent reflux patterns, which have been 
described in previous studies (4, 8). In-
competent valves at the SFJ were the 
major determinants for the descending 
reflux type. In the descending type, 
reflux occurred from the GSV to the 
PTCV-GV and the varicose veins.
The second reflux type, which was 
rare, was ascending reflux, in which a 
particular antigravitational upward di-
astolic flow from the saphenopopliteal 
junction (SPJ) was a major determi-
nant of the “paradoxical” reflux pat-
tern. Nevertheless, diastolic flow was 
too slow to be detected by Doppler US 
examination. For this reason, we also 
determined whether the proximal SSV 
and distal GV segments had increased 
diameter. Additionally, detection of 
incompetent valves at the SPJ was also 
used as a determinant of ascending 
reflux. In the ascending type, reflux 
occurred from SPJ to the GV and the 
varicose veins.
The third reflux type was character-
ized by deep-to-superficial reflux and 
was easily identified as a perforator 
vein reflux. The latter was considered 
when there was an obvious (larger than 
4 mm in diameter) incompetent perfo-
rator associated with the GVI, resulting 
in varicose veins. The critical finding 
for this pattern was the visualization 
of competent saphenous veins in all 
segments, particularly at the point of 
connection with the GV. 
The fourth and last group of patients 
had isolated GVI without any obvious 
reflux origin. If the varicose veins were 
related to a large GV with findings of 
insufficiency on Doppler US and none 
of the other reflux types were observed, 
then it was considered as GVI without 
any obvious reflux origin.
Ablation of GVI was performed in 17 
limbs in 17 patients (11 females, 64%; 
mean age, 42 years; age range, 21–68 
years). The distribution of the various 
patterns of refluxes is shown in Fig. 2, 
and the distribution of the ablated 
veins and vein segments according 
to the reflux patterns is summarized 
in Table 1. In two cases, the proximal 
GSV, SSV, and GV were ablated with 
the same fiber during the same session 
with only a single distal puncture. This 
long ablation segment was achieved by 
US guidance and turning the patient 
from a prone position to an oblique 
position for the visualization of the la-
ser fiber at the SFJ. Two patients who 
had total GSV ablation required a sec-
ond puncture for the distal GSV abla-
tion during the same session. One pa-
tient had anterior accessory saphenous 
vein ablation and one patient had a 
major tributary vein ablation during 
the same treatment session as the pa-
tients with total GSV. In six patients, 
GVI was diagnosed without any trun-
cal reflux. For these patients, only the 
GV ablation was performed, and the 
GSV was totally preserved. In three pa-
tients, the GSV distal to the PTCV-GSV 
junction was preserved. In one patient 
with ascending reflux, SSV and GV 
ablation was performed and the GSV 
was totally preserved. None of these 
patients had recurrent varicose veins 
at the first-year follow-up.
The mean diameter of the GV was 
5.2 mm (range, 3.7–7.1 mm) before 
the ablations. Continued closure of 
the ablated GV was observed in all 17 
limbs (100%) at one- and six-month 
follow-ups. Four patients did not re-
turn for 12-month follow-up; howev-
er, none of the 13 limbs evaluated at 
12-month follow-up showed recanali-
zation (100%). The large varicose veins 
treated by US-guided foam sclerother-
apy demonstrated no visible vascular-
ity and no compressibility along their 
entire course in 17/17 available limbs 
(100%) at the six-month follow-up. 
The volume of injected foam ranged 
from 2 to 10 mL (mean, 4.4 mL). An 
additional US-guided foam sclerother-
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Table 1. The distribution of ablated veins and vein segments according to the reflux pat-
terns  
Ablated vein/vein  Reflux Preserved saphenous 
segments  type vein n (%)
GSVtotal, GV, and SSV Descending and ascending none 2 (11.7)
GSVtotal and GV  Descending  SSV 5 (29.4)
GSVproximal and GV Descending SSV and distal GSV 3 (17.6)
SSV and GV Ascending GSV 1 (5.8)
GV and perforator vein Deep to superficial GSV 3 (17.6)
Only GV None (isolated GVI) GSV 3 (17.6)
GSVtotal, great saphenous vein (GSV) segment from the saphenofemoral junction to the level at which 
insufficiency was extended; GV, Giacomini vein; SSV, small saphenous vein; GSVproximal, GSV segment 
proximal to the GSV- posterior thigh circumflex vein junction; GVI, Giacomini vein insufficiency.
Table 2. Clinical outcomes of targeted endovenous treatment of Giacomini vein insufficien-
cy after six months (n=17)  
  Preoperative  Postoperative
  median (range) median (range) P
CEAP clinical score  3 (2–5) 1 (0–4) <0.001
rVCSS  7 (2–12) 1 (0–7) <0.001
CEAP, clinical etiological anatomical and pathophysiological classification; rVCSS, revised venous clinical 
severity score. 
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apy session for varicose veins was re-
quired in only one limb, at one-month 
follow-up visit. All patients were CEAP 
class two or greater and symptomatic 
before the treatment. At six months, 
the median CEAP classification score 
decreased from 3 (range, 2–5) before 
the procedure to 1 (0–4), while median 
rVCSS decreased from 7 (range, 2–12) 
before the procedure to 1 (range, 0–7) 
(Table 2). Clinical outcomes measured 
by CEAP and rVCSS showed significant 
improvement compared with the pre-
treatment scores (P < 0.001). 
There were no complications oth-
er than the expected postprocedural 
complaints of pain, bruising, and cord-
like tightening along the course of the 
treated vein. Hyperpigmentation was 
noted in 10 limbs (58%) at one-month 
follow-up (Fig. 3). Pigmentation either 
improved significantly or disappeared 
completely in all limbs at six-month 
follow-up (Fig. 4). Photographs taken 
before and after the procedure showed 
full resolution of varicose veins in 15 
patients and improvement in two pa-
tients. Symptoms resolved completely 
or improved greatly, by the six-month 
follow-up in all patients. There were 
no significant complications such as 
skin burns, necrosis, paresthesia, deep 
vein thrombosis, or allergic reaction.
Discussion
In the present study, GVI-associated 
varicose disease patients with different 
reflux patterns (ascending reflux, de-
scending reflux, deep-to-superficial re-
flux via perforator veins) and patients 
without an obvious reflux source were 
treated using the TET approach, aiming 
to preserve GSVs totally or partially. 
We preserved seven GSVs totally and 
three GSVs partially (10/17, 58%) us-
ing the TET approach for the treatment 
of GVI-associated varicose disease.
Truncal reflux is usually associated 
with GSV and SSV as a cause of vari-
cose veins. Reflux in other incompetent 
veins leading to varicose disease is less 
common (17), but it has prompted in-
creasing clinical interest as advanced 
endovenous techniques have become 
available. Varicose disease due to a GVI 
can be observed in clinical practice and 
is not very rare (3, 4, 18). The prevalence 
of reflux in the GV ranges from 2% to 
19% (16, 18–20). However, primary var-
Figure 2. a–d. Reflux patterns of incompetent vein/vein segments and their relation to the GV: (a), 
descending reflux pattern with incompetent proximal GSV-PTCV-GV; (b), ascending reflux pattern 
with incompetent GV and SSV; (c), deep-to-superficial reflux pattern with incompetent thigh 
perforator vein and GV; (d), isolated GVI and related varicose veins with no other reflux sources. 
GSV, great saphenous vein; FV, femoral vein; PTCV, posterior thigh circumflex vein; VV, varicose 
veins; GV, Giacomini vein; SSV, small saphenous vein; Pop V, popliteal vein; PV, perforator vein.
c d
a b
Endovenous treatment of Giacomini vein insufficiency-associated varicose disease • 485
icose veins due to SPJ insufficiency with 
anterograde diastolic flow are fairly rare, 
and they accounted for 1% of the pa-
tients in a previous study (8). Compara-
ble to previous reports, the present study 
showed that the GV was affected in 5% 
of the limbs with varicose veins treated 
with ELA. Less than 1% of the patients 
had ascending reflux. GVI without trun-
cal reflux was observed in 1.7%. 
Since ELA of the saphenous vein was 
initially reported in 2001 (21, 22), sev-
eral studies have been conducted using 
ELA as a minimally invasive modality 
for the treatment of different incompe-
tent veins (4, 13, 23–25). Escribano et 
al. (8) reported a hemodynamic strat-
egy for the surgical treatment of dia-
stolic anterograde reflux of GV. In that 
study, 16 limbs had retrograde flow 
from the GSV to the incompetent GV, 
and two limbs had paradoxical reflux. 
All patients were treated using surgery, 
such as phlebectomy and division of 
the GV and collaterals, but GSV was 
preserved in all procedures. 
There are only a few studies describ-
ing ELA treatment for GVI in the lit-
erature (3, 7, 13). Theivacumar et al. 
(4) reported two patients who had GVI 
with competent proximal GSV and 
incompetent GSV distal to the drain-
ing point of the GV. They treated the 
distal GSV with ELA and left the GV 
without treatment. Bush and Ham-
mond (2) reported ELA treatment of 
14 patients with GVI with successful 
outcomes. In their study, the thigh ex-
tension branch anatomy was grouped 
into three categories according to the 
anatomy of the GV and a subgroup 
was described in which the GV ended 
in the femoral vein via a perforator. 
Park et al. (7) reported the treatment of 
18 limbs by ablating both the GV and 
the proximal GSV.
Ideally, the source of the refluxes 
in GVI, such as the insufficiency of 
the GSV, SPJ, or a related thigh per-
forator vein, should be treated by a 
specific, minimally invasive method. 
Saphenous vein-focused surgical ther-
apies may result in overtreatment or 
undertreatment. TET seems to be an 
effective alternative to these therapies. 
Using this approach, we were able to 
spare the GSV in 58% of the patients, 
whereas it would normally need to be 
Figure 4. a, b. Endovenous laser ablation of Giacomini vein insufficiency-associated varicose 
veins. A 41-year-old woman with varicose veins in the right lower extremity with a descending 
(retrograde) reflux pattern (a). The appearance of varicose veins was markedly improved at 
six-month follow-up after targeted endovenous treatment of GV and SSV (b). There is no skin 
pigmentation at the varicose vein trace.
a b
Figure 3. a–c. Endovenous laser ablation of Giacomini vein insufficiency-associated varicose veins. Doppler US image (a) shows the relation 
of perforator vein and GV. A 38-year-old man with varicose veins in the left lower extremity with a deep-to-superficial reflux pattern due to a 
perforator vein (b). The appearance of the varicose veins was markedly improved at one-month follow-up after targeted endovenous treatment, 
with mild hyperpigmentation (c). 
a b c
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removed using the standard surgical 
approach. By preserving the GSV, the 
natural hemodynamics of the super-
ficial venous network were preserved, 
and the loss of potential arterial bypass 
grafts was prevented. In addition, less 
effective therapies, such as perform-
ing a GSV ablation and leaving an un-
treated perforator reflux source, can be 
avoided by this approach. 
Our study has some limitations 
and shortcomings. First, the patient 
follow-up data collection over the 
12-month follow-up was not com-
plete. Second, endovenous treatment 
is not yet accepted as a common treat-
ment technique for the GV. Howev-
er, we believe that the incidence and 
outcome of complications in our study 
were similar or better compared to oth-
er ELA studies that reported the inci-
dence of complications. 
In conclusion, TET considering all 
reflux sources, including incompetent 
GSV segments, SPJ, and the perforator 
veins, is an effective and safe procedure 
with good technical success rates for 
treating GVI-associated varicose dis-
ease. Using this technique, saphenous 
veins can be preserved in the majority 
of GVI cases. Long-term studies with 
larger series are required to confirm the 
advantages of TET for the GVI. 
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